Antagonistic antibody prevents toll-like receptor 2 --driven lethal shock-like syndromes.

Autor: Guangxun Meng1, Rutz, Mark1, Schiemann, Matthias1, Metzger, Jochen2, Grabiec, Alma1, Schwandner, Ralf3, Luppa, Peter B.2, Ebel, Frank4, Busch, Dirk H.1, Bauer, Stefan1, Wagner, Hermann1, Kirschning, Carsten J.1 kirschning@lrz.tum.de.
Zdroj: Journal of Clinical Investigation. May2004, Vol. 113 Issue 10, p1473-1481. 9p. 2 Color Photographs, 1 Black and White Photograph, 6 Graphs.
Databáze: Academic Search Ultimate